Leading the way to safer medication
 Crosscheck  Recommender


Therapeutic Indications

Bendroflumethiazide is indicated for:

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral


Active ingredient Bendroflumethiazide is contraindicated in the following cases:

No gender/age discrimination

at least one of
Hepatic insufficiency

Renal failure

Primary adrenocortical insufficiency

Peptic ulcer